Skip to main content
. 2019 Apr 19;19(2):191–200. doi: 10.1007/s40268-019-0270-3

Table 1.

Baseline demographics

Demographics Study 1: Local nasal tolerability in healthy volunteers Study 2: Efficacy in common cold symptoms
0.5% Carbomer 980 gel nasal spray (n = 20) Placebo nasal spray (n = 10) 0.5% Carbomer 980 gel nasal spray (n = 87) Placebo nasal spray (n = 81)
Sex
 Female 10 (50) 5 (50) 57 (65.5) 56 (69.1)
 Male 10 (50) 5 (50) 30 (34.5) 25 (30.9)
Race
 White 15 (75) 10 (100) 51 (58.6) 53 (65.4)
 Black 5 (25) 0 35 (40.2) 28 (34.6)
 Other 0 0 1 (1.1) 0
Ethnicity
 Hispanic/latino 2 (10) 1 (10) 6 (6.9) 6 (7.4)
 Not hispanic/latino 18 (90) 9 (90) 81 (93.1) 75 (92.6)
Age, years 36.8 ± 10.0 34.1 ± 7.4 49.8 ± 14.0 50.3 ± 12.6

Data are presented as n (%) or mean ± standard deviation unless otherwise indicated